Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication

C Hu, W Jia - Diabetes, 2018 - Am Diabetes Assoc
The incidence of type 2 diabetes (T2D) has rapidly increased over recent decades, and T2D
has become a leading public health challenge in China. Compared with European …
被引用次数：391 相关文章

Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication

C Hu, W Jia - Diabetes, 2018 - pubmed.ncbi.nlm.nih.gov
The incidence of type 2 diabetes (T2D) has rapidly increased over recent decades, and T2D
has become a leading public health challenge in China. Compared with European …

Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication

C Hu, W Jia - Diabetes, 2017 - cir.nii.ac.jp
抄録< jats: p> The incidence of type 2 diabetes (T2D) has rapidly increased over recent
decades, and T2D has become a leading public health challenge in China. Compared with …

Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication

C Hu, W Jia - Diabetes, 2018 - hero.epa.gov
The incidence of type 2 diabetes (T2D) has rapidly increased over recent decades, and T2D
has become a leading public health challenge in China. Compared with European …

Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication.

C Hu, W Jia - Diabetes, 2018 - europepmc.org
The incidence of type 2 diabetes (T2D) has rapidly increased over recent decades, and T2D
has become a leading public health challenge in China. Compared with European …